Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.

Literature DB >> 3114329

Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.

V Malacrida, D De Francesco, G Banfi, F A Porta, P G Riches.

Abstract

Protein electrophoresis was carried out on 102,000 samples from the patients of a district general hospital over 10 years, and a monoclonal protein was detected in 730 cases; of these, 114 could be classified as B cell malignancies and 261 as monoclonal gammopathy of undefined significance (MGUS). The various clinical and laboratory features of monoclonal gammopathy were examined with respect to distinguishing the malignant conditions from MGUS at first presentation.

Entities: Disease Species

Mesh：

Substances：

Year: 1987 PMID： 3114329 PMCID： PMC1141100 DOI： 10.1136/jcp.40.7.793

Source DB: PubMed Journal: J Clin Pathol ISSN： 0021-9746 Impact factor: 3.411

20 in total

1. Idiopathic (asymptomatic) monoclonal gammopathies.

Authors: S E Ritzmann; D Loukas; H Sakai; J C Daniels; W C Levin
Journal: Arch Intern Med Date: 1975-01

2. Paraproteins, benign or malignant?

Authors: J R Hobbs
Journal: Br Med J Date: 1967-09-16

3. Studies of "benign" serum M-components.

Authors: R C Williams; R C Bailly; R B Howe
Journal: Am J Med Sci Date: 1969-05 Impact factor: 2.378

4. Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics.

Authors: F Dammacco; J Waldenström
Journal: Acta Med Scand Date: 1968-11

5. Idiopathic Bence Jones proteinuria--a distinct entity?

Authors: R A Kyle; J E Maldonado; E D Bayrd
Journal: Am J Med Date: 1973-08 Impact factor: 4.965

6. M-components.

Authors: N Abramson; S J Shattil
Journal: JAMA Date: 1973-01-08 Impact factor: 56.272

7. Monoclonal gammopathy in human neoplasia.

Authors: P J Migliore; R Alexanian
Journal: Cancer Date: 1968-06 Impact factor: 6.860

8. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases.

Authors: T Isobe; E F Osserman
Journal: Ann N Y Acad Sci Date: 1971-12-31 Impact factor: 5.691

9. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors: S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal: N Engl J Med Date: 1975-10-30 Impact factor: 91.245

10. Transient paraproteinaemia in a patient with coeliac disease.

Authors: A S Pena; J V Nieuwkoop; H R Schuit; W T Hekkens; A J Haex
Journal: Gut Date: 1976-09 Impact factor: 23.059

11 in total

1. Use of cytoplasmic 5'nucleotidase for differentiating malignant from benign monoclonal gammopathies.

Authors: G Majumdar; S E Heard; A K Singh
Journal: J Clin Pathol Date: 1990-11 Impact factor: 3.411

2. The relationship between hypogammaglobulinemia, monoclonal gammopathy of undetermined significance and humoral immunodeficiency: a case series.

Authors: Robert Marc Zemble; Patricia A Takach; Arnold I Levinson
Journal: J Clin Immunol Date: 2011-06-05 Impact factor: 8.317

Review 3. Prevalence, clinical aspects, and natural history of IgM MGUS.

Authors: Mary L McMaster; Ola Landgren
Journal: Cytometry B Clin Cytom Date: 2010 Impact factor: 3.058

4. Prognostic significance of paraproteinaemia in rheumatoid arthritis.

Authors: C Kelly; G Baird; H Foster; H Hosker; I Griffiths
Journal: Ann Rheum Dis Date: 1991-05 Impact factor: 19.103

5. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Authors: Giada Bianchi; Robert A Kyle; Colin L Colby; Dirk R Larson; Shaji Kumar; Jerry A Katzmann; Angela Dispenzieri; Terry M Therneau; James R Cerhan; L Joseph Melton; S Vincent Rajkumar
Journal: Blood Date: 2010-05-21 Impact factor: 22.113

Review 6. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.

Authors: Rishi K Wadhera; S Vincent Rajkumar
Journal: Mayo Clin Proc Date: 2010-08-16 Impact factor: 7.616

Review 7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Authors: Amit Agarwal; Irene M Ghobrial
Journal: Clin Cancer Res Date: 2012-12-05 Impact factor: 12.531

8. A clinical decision rule to aid ordering of serum and urine protein electrophoresis for case-finding of paraproteins in hospitalized inpatients.

Authors: Ammarin Thakkinstian; Huy Tran; Glenn Reeves; Stuart Murch; John Attia
Journal: J Gen Intern Med Date: 2008-07-30 Impact factor: 5.128

9. Ankylosing spondylitis and monoclonal gammopathies.

Authors: G Renier; J C Renier; M Gardembas-Pain; A Chevailler; M Boasson; D Hurez
Journal: Ann Rheum Dis Date: 1992-08 Impact factor: 19.103

10. Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study.

Authors: Ling Ma; Shuang Xu; Jianhua Qu; Jian Hou; Yang Wang; Lei Wen; Yang Liu; Ying Kang; Ming Jiang; Weijun Fu; Juan Du; Lin Zhou; Xiaojun Huang; Zhaoxia Zhang; Jin Lu
Journal: Hematol Oncol Date: 2018-10-01 Impact factor: 5.271